First Annual National Lymphoma Awareness Week

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 9
Volume 5
Issue 9

LOS ANGELES, Calif--The first annual National Lymphoma Awareness Week, sponsored by the Lymphoma Research Foundation of America, is scheduled for October 13 to 19. Members of the Foundation will launch local awareness activities and educational events throughout the week to inform the public about lymphatic cancers.

LOS ANGELES, Calif--The first annual National Lymphoma AwarenessWeek, sponsored by the Lymphoma Research Foundation of America,is scheduled for October 13 to 19. Members of the Foundation willlaunch local awareness activities and educational events throughoutthe week to inform the public about lymphatic cancers.

Actress Jamie Lee Curtis serves as Honorary Chair for AwarenessWeek. Actress Tracy Nelson, daughter of the late singer Rick Nelson,is a Hodgkin's lymphoma survivor and acts as spokesperson forthe Lymphoma Research Foundation. Both actresses have recordeda series of informative public service radio announcements aboutthe disease.

The Lymphoma Research Foundation of America was organized in 1991to raise funds to support research projects seeking to cure lymphomaand find better, safer treatments. To date, 32 research grantshave been awarded.

Internet Site

The Lymphoma Research Foundation also sponsors lymphoma supportgroups, provides programs and resource referrals for patients,publishes a newsletter, and maintains an informative site on theInternet that can be reached at: http://www.lymphoma.org.

Recent Videos
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
Related Content